References
1. Warshaw AL, del Castillo CF. Pancreatic carcinoma. N Engl J Med. 1992; 326:455–465.
2. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349:485–489.
3. Egawa S, Toma H, Ohigashi H, et al. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas 2012; 41:985–992.
4. Kanno A, Masamune A, Hanada K, et al; Japan Study Group on the Early Detection of Pancreatic Cancer (JEDPAC). Multicenter study of early pancreatic cancer in Japan. Pancreatology 2018; 18:61–67.
5. Yamaguchi K, Okusaka T, Shimizu K, et al; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society. Clinical practice guidelines for pancreatic cancer 2016 from the Japan Pancreas Society: a synopsis. Pancreas 2017; 46:595–604.
6. Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas 2012; 41:523–529.
7. Kikuyama M, Hanada K, Ueki T. Pancreatic carcinoma in situ presenting prominent fatty change of the pancreatic body on CT: experiences from 3 cases. In Japanese with English Abstract. Suizo 2015; 30:626–632.
8. Miyata T, Takenaka M, Omoto S, et al. A case of pancreatic carcinoma in situ diagnosed by repeated pancreatic juice cytology. Oncology 2017; 93:98–101.
9. Hanada K, Okazaki A, Hirano N, et al. Diagnostic strategies for early pancreatic cancer. J. Gastroenterol 2015; 50:147–154.
10. Seki M, Ninomiya E, Takano K, et al. Pancreatogram findings for carcinoma in situ (CIS) of the pancreas seen on endoscopic retrograde cholangiopancreatography and postoperative pancreatography of resected specimens: can CIS be diagnosed preoperatively? Pancreatology 2008; 8:142–152.
11. Ikeda M, Yanagisawa A, Seki M, et al. The early state of invasive pancreatic ductal adenocarcinomas: characteristics of the low papillary type and flat type intraductal carcinoma. Pancreas 2006; 33:135–141.
12. Uesaka K, Boku N, Fukutom A, et al.: JASPAC 01 Study Group. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 2016; 388:248–257.
13. Sugita H, Kuroki H, Akiyama T, et al. Hand-assisted laparoscopic spleen-preserving distal pancreatectomy combined with laparoscopic distal gastrectomy for the treatment of pancreatic neuroendocrine tumor with early gastric cancer: Report of a case. Int J Surg Case Rep. 2016; 28: 258–261.